WATER INDUSTRY FEATURES, INSIGHTS, AND ANALYSIS
-
Putting The National Toxicology Program's Fluoride Review In Context
Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
-
Opinion: Why PFAS Policymakers Should Read Past The Abstract When it comes to drinking water, sound public policy requires sound scientific research. Publication in a prestigious, peer-reviewed journal helps establish legitimacy for scientific claims in public discourse. But science is a social process, scientific standards of evidence vary across disciplines, and peer review does not guarantee validity. For readers who stop at the abstract, these distinctions can be easy to miss.
-
Planting The Seeds Of Inspiration: Eelgrass Restoration
Restoring eelgrass beds is critical because they provide habitat for many kinds of marine life, improve water quality by filtering out pollution, and the plant’s root system stabilizes the sediment on the seafloor, protecting shorelines from erosion.
-
PFAS Are Turning Up In The Great Lakes, Putting Water Supplies At Risk — Here's How They Get There No matter where you live in the U.S., you have likely seen headlines about PFAS being detected in everything from drinking water to fish to milk to human bodies. Now, PFAS are posing a threat to the Great Lakes, one of America’s most vital water resources.
-
Why Too Much Phosphorus In America's Farmland Is Polluting The Country's Water When people think about agricultural pollution, they often picture what is easy to see: fertilizer spreaders crossing fields or muddy runoff after a heavy storm. However, a much more significant threat is quietly and invisibly building in the ground.
-
Water In 2026: The Nexus Of Policy, Technology, And Resilience As water systems become more circular and complex, understanding and managing the subsurface — the hidden half of the water cycle — is becoming a critical enabler of resilience. This article explores the key trends shaping this new reality, from tackling “forever chemicals” to the water strategies redefining heavy industry.
-
PFAS In Pregnant Women's Drinking Water Puts Their Babies At Higher Risk, Study Finds
When pregnant women drink water that comes from wells downstream of sites contaminated with PFAS, known as “forever chemicals,” the risks to their babies’ health substantially increase, a new study found. These risks include the chance of low birth weight, preterm birth, and infant mortality.
-
PFAS Settlements: Debunking The Myths And Revealing What's Really At Stake For Water Utilities Misinformation and confusion could prevent some utilities from benefitting from the aqueous film-forming foam multidistrict litigation (AFFF MDL) settlements. Here are five common myths about the AFFF MDL PFAS settlements and how public water systems can make the most of this unprecedented funding opportunity.
-
When Chemistry Meets Water Innovation
Nobel-winning molecular materials are poised to reinvent purification, desalination, and reuse.
-
Solving The World's Microplastics Problem: 4 Solutions Cities And States Are Trying After Global Treaty Talks Collapsed
Microplastics seem to be everywhere — in the air we breathe, the water we drink, the food we eat. Countries have tried for the past few years to write a global plastics treaty that might reduce human exposure, but the latest negotiations collapsed in August 2025. While U.S. and global solutions seem far off, policies to limit harm from microplastics are gaining traction at the state and local levels.
VIEWS ON THE LATEST REGS
-
In this Q&A, Dr. Elke Süss of Metrohm addresses the urgent need for haloacetic acid testing in response to “one of the most significant updates to EU drinking water monitoring in recent years.”
-
With the U.S. EPA's PFAS rules now in place, utilities are finding themselves with a growing number of questions regarding how to treat these chemicals, the potential costs, and much more. For answers, Water Online's chief editor, Kevin Westerling, hosted an Ask Me Anything session featuring Ken Sansone, Senior Partner at SL Environmental Law Group; Kyle Thompson, National PFAS Lead at Carollo Engineers; and Lauren Weinrich, Principal Scientist at American Water.
-
A Q&A to explain and resolve issues confronting water suppliers as they endeavor to comply with the monitoring requirements of federal PFAS regulations.
-
Assessing what lies ahead in the 10-year race to go lead-free, otherwise known as the Lead and Copper Rule Improvements (LCRI).
-
Many water systems are still tackling the challenge of identifying and compliantly managing galvanized and galvanized-requiring-replacement (GRR) service lines.
MORE WATER INDUSTRY FEATURES
-
Aseptic processing sterilizes products and packaging separately, then combines them in a sterile environment. See how this method ensures safety, extends shelf life, and protects medicines from contamination.
-
Learn five essential best practices to maintain a sterile incubator shaker environment, from routine cleaning and humidity control to advanced HEPA filtration for reliable results.
-
SWIR photoluminescence imaging enables fast, contactless inspection of photovoltaic materials, detecting defects and performance indicators with high efficiency, minimal preparation, and real-time imaging capability.
-
Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.
-
Standard spectrometers struggle with steep edges and high OD. IDEX’s Peregrine and KolaDeep™ systems offer superior spectral resolution and sensitivity for precise optical filter measurement.
-
Sterile drug filtration demands rigorous integrity testing to prevent contamination. Learn how PUPSIT and in situ leak testing strengthen compliance with EU GMP Annex 1 and ensure reliable manufacturing.
-
Discover how digital twins are enabling the optimization of cell culture processes for improved, more predictable outcomes in the creation of therapeutic proteins and antibodies.
-
In the picturesque village of Arzacq-Arraziguet in southwestern France, a critical water pipeline repair showcased the efficiency of modern tools and techniques.
-
Regulators are increasingly favoring in vitro methods to prove bioequivalence, though differing guidelines and a new focus on matching reference product structures pose challenges.
-
Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
-
In this article, we outline the sources, occurrence, known health issues, and mitigation options for specific contaminants.
-
TMF document processing requires a delicate balancing act. Sponsors strive for accuracy and completeness, but timeliness is crucial. How can teams achieve all three? Here are some practical strategies.
-
Discover how N-1 intensification shortens production timelines and improves cell viability by replacing traditional filtration with automated, low-shear separation techniques to achieve higher seeding densities.
-
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
-
Discover how science-based bio-decontamination strategies effectively eliminate invisible pathogens and rapidly restore facilities to operational safety following major infrastructure disruptions.
-
A CDMO guide to implementing EU Annex 1 for modern sterile fill/finish facilities, covering cleanroom design, contamination control, utilities, personnel, monitoring, and audit essentials.
-
Learn how real-time monitoring with PAT enhances process control, shortens development timelines, and supports the shift toward continuous manufacturing in biopharmaceutical production.
-
Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.